Survival differences in women with serous tubal, ovarian, peritoneal, and uterine carcinomas

Irina Usach, Kevin Blansit, Lee May Chen, Stefanie Ueda, Rebecca Brooks, Daniel S. Kapp, John K. Chan

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Abstract

Objective The fallopian tube has been implicated as the primary origin of pelvic serous cancers. We proposed to determine the survival outcomes of serous tubal, ovarian, peritoneal, and uterine cancer patients. Study Design Data were obtained from the National Cancer Institute between 2004 and 2009. Kaplan-Meier and Cox proportional hazards models were used for analysis. Results Of 12,336 high-grade serous cancer patients, 563 were tubal (TC), 8560 ovarian (OC), 1037 primary peritoneal (PPC), and 2176 uterine cancer (USC). The median ages of these patients were 63 vs 62 vs 67 vs 68 years, respectively. The majority were white (89% vs 88% vs 91% vs 74%). The overall 5 year, disease-specific survival was 37%. The survivals of those with TC, OC, PPC, and USC were 50%, 37%, 26%, and 40% (P <.01). There was no detailed staging on PPC cancers. Adjusted for stage, the survival of those with stage I, II, III, and IV TC were 73%, 62%, 44%, and 22% (P <.01), OC were 83%, 64%, 34%, and 15% (P <.01), and USC were 88%, 72%, 55%, and 17% (P <.01). On multivariate analysis, younger age, white race, earlier stage, and tubal origin were independent predictors for improved survival. Conclusion In advanced-staged serous cancer patients, tubal cancer patients have better survivals compared with ovarian, peritoneal, and uterine cancer.

Original languageEnglish (US)
Pages (from-to)188.e1-188.e6
JournalAmerican journal of obstetrics and gynecology
Volume212
Issue number2
DOIs
StatePublished - Feb 1 2015
Externally publishedYes

Keywords

  • cancer origin
  • endometrial cancer
  • ovarian cancer
  • serous cancer
  • survival analysis

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Fingerprint Dive into the research topics of 'Survival differences in women with serous tubal, ovarian, peritoneal, and uterine carcinomas'. Together they form a unique fingerprint.

Cite this